Abstract
Objective
Methods
Results
Conclusion
Notes
FUNDING INFORMATION
This work was partly supported by Research Funding of AHS-RD (No. 65001) University of Phayao, Phayao, Thailand; and Thailand Science Research and Innovation Fund and the University of Phayao (Grant No. FF66-RIM082).
AUTHOR CONTRIBUTION
Conceptualization: Kaewjoho C, Khamnon N. Data curation: Kaewjoho C, Ladawan S. Methodology: Kaewjoho C, Poncumhak P, Manoy P. Formal analysis: Kaewjoho C, Poncumhak P, Khamnon N. Funding acquisition: Kaewjoho C. Project administration: Kaewjoho C. Supervision: Khamnon N. Visualization: Ladawan S. Writing – original draft: Kaewjoho C. Writing – review and editing: Poncumhak P, Manoy P, Ladawan S, Khamnon N. Approval of final manuscript: all authors.
REFERENCES








































Fig. 2.

Table 1.
Table 2.
Outcome | Soft surface stepping exercise within-group difference | Firm surface stepping exercise within-group difference | Between groups difference p-value (95% CI) | Partial eta squared (ηp²) |
---|---|---|---|---|
TUGT (s) | ||||
Pre-test | 10.89±2.50 (9.56–12.22) | 10.87±2.10 (9.76–11.99) | 0.985 (-1.65 to 1.68) | 0.000 |
4 wk | 8.55±1.38 (7.812–9.28)* | 9.31±1.16 (8.56–10.06) | 0.133 (-1.77 to 0.24) | 0.074 |
6 wk | 8.11±1.09 (7.75–8.69)** | 9.06±1.18 (8.35–9.78)* | 0.035 (-1.83 to -0.07) | 0.140 |
1 mo (follow-up) | 8.49±1.52 (7.63–9.25)* | 8.88±1.66 (7.99–9.76)** | 0.465 (-1.53 to 0.76) | 0.015 |
BLCD (kg) | ||||
Pre-test | 46.07±13.03 (39.12–53.01) | 40.23±9.95 (34.93–45.54) | 0.165 (-2.54 to 14.20) | 0.063 |
4 wk | 59.97±15.21 (51.86–68.08)** | 51.30±12.80 (44.48–58.12)* | 0.091 (-1.47 to 18.82) | 0.092 |
6 wk | 63.46±14.17 (55.91–71.01)** | 52.15±10.25 (46.68–57.61)** | 0.015 (2.38 to 20.24) | 0.182 |
1 mo (follow-up) | 58.94±14.68 (51.12–66.77)* | 49.06±14.67 (41.24–56.87) | 0.066 (-0.71 to -20.48) | 0.108 |
FTSST (s) | ||||
Pre-test | 12.64±2.12 (11.51–13.77) | 12.02±2.70 (10.93–13.13) | 0.416 (-0.90 to 2.12) | 0.022 |
4 wk | 10.24±2.70 (8.80–11.68)* | 10.99±1.96 (10.08–11.89) | 0.351 (-2.38 to 0.87) | 0.029 |
6 wk | 9.35±1.52 (8.54–10.15)** | 10.09±1.39 (9.35–10.83)** | 0.158 (-1.79 to 0.30) | 0.065 |
1 mo (follow-up) | 9.21±1.38 (8.47–9.94)** | 10.09±1.44 (9.32–10.86)* | 0.087 (-1.89 to 1.13) | 0.094 |
Walking ability (m/s) | ||||
10MWT prefer speed | ||||
Pre-test | 1.05±0.19 (0.95–1.15) | 0.89±0.39 (0.68–1.10) | 0.170 (-0.07 to 0.37) | 0.062 |
4 wk | 1.20±0.19 (1.10–1.31) | 1.13±0.22 (1.01–1.25) | 0.345 (-0.08 to 0.22) | 0.030 |
6 wk | 1.32±0.22 (1.20–1.44)* | 1.25±0.24 (1.13–1.38)* | 0.666 (-0.12 to 0.19) | 0.006 |
1 mo (follow-up) | 1.31±0.24 (1.18–1.44) | 1.14±0.16 (1.05–1.22) | 0.132 (-0.29 to 0.21) | 0.074 |
10MWT fasted speed | ||||
Pre-test | 1.39±0.11 (1.33–1.45) | 1.34±0.20 (1.24–1.45) | 0.107 (-0.02 to 0.27) | 0.084 |
4 wk | 1.51±0.31 (1.35–1.68) | 1.42±0.22 (1.30–1.53) | 0.931 (-0.20 to 0.22) | 0.000 |
6 wk | 1.69±0.23 (1.57–1.81)* | 1.56±0.19 (1.46–1.66)* | 0.697 (-0.13 to 0.19) | 0.005 |
1 mo (follow-up) | 1.43±0.23 (1.30–1.55) | 1.34±0.15 (1.26–1.42) | 0.206 (-0.05 to 0.23) | 0.053 |
Values are presented as mean±standard deviation (95% CI).
For the difference between groups at each time point analyzed using the 4×2 mixed-model analysis of variance.
The data comparisons within the group were analyzed at pre-test, 4 weeks, 6 weeks, and after 1 month follow-up.
CI, confidence interval; TUGT, Timed Up and Go test; BLCD, back-leg-chest dynamometer; FTSST, Five Times Sit-to-Stand test; 10MWT, 10 Meter Walk Test.
Table 3.
Outcome | Soft surface stepping exercise within-group difference | Firm surface stepping exercise within-group difference | Between groups difference p-value (95% CI) | Partial eta squared (ηp²) |
---|---|---|---|---|
Isometric muscle strength (kg) | ||||
Hip flexors | ||||
Pre-test | 9.04±2.08 (7.93–10.15) | 10.20±3.74 (8.21–12.20) | 0.283 (-3.35 to 1.01) | 0.038 |
4 wk | 11.81±4.76 (9.27–14.36) | 13.01±3.20 (11.30–14.72) | 0.410 (-4.13 to 1.73) | 0.023 |
6 wk | 16.52±3.42 (14.7–18.5)** | 14.11±3.58 (12.20–16.01)** | 0.041 (0.05 to 4.93) | 0.122 |
1 mo (follow-up) | 14.51±5.44 (11.61–17.41)** | 13.65±3.66 (11.69–15.60)* | 0.602 (-2.48 to 4.21) | 0.009 |
Hip extensors | ||||
Pre-test | 8.19±3.12 (6.52–9.85) | 9.05±3.26 (7.23–10.89) | 0.078 (-4.35 to 0.24) | 0.100 |
4 wk | 11.76±3.87 (6.52–9.85)* | 10.90±3.89 (8.83–12.97) | 0.533 (-1.93 to 3.66) | 0.013 |
6 wk | 16.81±3.56 (9.70–18.71)**,a) | 14.11±4.31 (11.81–16.41)** | 0.047 (0.06 to 7.48) | 0.126 |
1 mo (follow-up) | 14.39±4.80 (11.84–16.95)** | 14.58±4.80 (12.02–17.14)** | 0.602 (-5.48 to 3.23) | 0.009 |
Hip adductors | ||||
Pre-test | 7.57±3.08 (5.93–9.22) | 9.68±3.41 (7.86–11.49) | 0.078 (-4.45 to 0.24) | 0.100 |
4 wk | 11.34±2.62 (9.57–13.14)** | 10.31±3.92 (8.50–12.07) | 0.390 (-1.38 to 3.44) | 0.025 |
6 wk | 14.90±3.69 (13.62–16.98)**,b) | 12.10±3.01 (10.02–13.38)* | 0.026 (0.36 to 5.23) | 0.155 |
1 mo (follow-up) | 12.18±3.89 (10.36–14.46)* | 12.49±3.90 (10.22–14.32) | 0.822 (-3.12 to 2.50) | 0.002 |
Hip abductors | ||||
Pre-test | 7.35±1.99 (6.29–8.42) | 8.84±2.05 (7.75–9.94) | 0.055 (-0.06 to 5.12) | 0.117 |
4 wk | 11.12±3.46 (9.27–12.96)* | 9.52±2.61 (8.13–10.90) | 0.149 (-0.60 to 3.81) | 0.068 |
6 wk | 15.32±2.94 (13.75–16.88)**,b) | 12.79±4.14 (10.58–14.98)** | 0.046 (-2.95 to -0.03) | 0.127 |
1 mo (follow-up) | 14.04±3.63 (12.10–15.97)** | 13.75±4.59 (11.30–16.19)** | 0.842 (-2.69 to 3.27) | 0.001 |
Knee flexors | ||||
Pre-test | 8.41±1.59 (7.57–9.26) | 8.38±2.09 (7.62–9.14) | 0.939 (-1.48 to 1.59) | 0.000 |
4 wk | 11.14±3.58 (9.23–13.04) | 10.27±3.57 (8.98–11.56) | 0.175 (-0.81 to 4.27) | 0.060 |
6 wk | 14.67±3.37 (12.88–16.47)** | 13.38±4.00 (11.94–14.82)** | 0.067 (-0.19 to 5.35) | 0.107 |
1 mo (follow-up) | 13.15±2.86 (11.62–14.68)** | 12.46±2.68 (11.49–13.43)** | 0.152 (-0.53 to 3.27) | 0.067 |
Knee extensors | ||||
Pre-test | 9.15±1.52 (8.34–9.97) | 10.12±1.96 (9.07–11.16) | 0.130 (-2.24 to 0.30) | 0.075 |
4 wk | 15.06±3.51 (13.19–16.93)** | 14.46±4.84 (11.87–17.03)* | 0.691 (-2.45 to 3.65) | 0.005 |
6 wk | 19.68±4.72 (17.17–22.20)**,a) | 17.22±3.99 (15.09–19.34)** | 0.122 (-0.69 to 5.61) | 0.078 |
1 mo (follow-up) | 17.28±4.21 (15.03–19.52)** | 17.86±5.05 (15.17–20.55)** | 0.723 (-3.94 to 2.76) | 0.004 |
Ankle dorsiflexors | ||||
Pre-test | 6.43±1.36 (5.70–7.15) | 6.80±1.24 (6.13–7.46) | 0.430 (-1.31 to 0.57) | 0.021 |
4 wk | 9.05±2.84 (7.54–10.56)* | 8.67±2.34 (7.42–9.91) | 0.680 (-1.49 to 2.26) | 0.006 |
6 wk | 13.42±5.16 (10.67–16.17)** | 12.12±3.51 (10.25–13.99)**,a) | 0.412 (-1.88 to 4.48) | 0.023 |
1 mo (follow-up) | 13.03±4.25 (10.82–15.23)** | 12.48±4.04 (10.33–14.64)** | 0.708 (-2.40 to 3.50) | 0.005 |
Ankle plantarflexes | ||||
Pre-test | 8.31±1.91 (7.29–9.33) | 8.61±1.93 (7.58–99.64) | 0.664 (-1.68 to 1.09) | 0.006 |
4 wk | 11.12±2.69 (9.68–12.55)* | 9.66±2.78 (8.18–11.15) | 0.143 (-0.52 to 3.42) | 0.070 |
6 wk | 14.33±5.86 (11.21–17.46)* | 13.05±4.03 (10.92–15.20)** | 0.477 (-2.35 to 4.91) | 0.017 |
1 mo (follow-up) | 13.72±3.02 (12.11–15.32)**,c) | 13.42±4.82 (10.84–15.99)* | 0.834 (-2.60 to 3.20) | 0.001 |
Values are presented as mean±standard deviation (95% CI).
For the difference between groups at each time point analyzed using the 4×2 mixed-model analysis of variance.
The data comparisons within the group were analyzed at pre-test, 4 weeks, 6 weeks, and after 1 month follow up.
CI, confidence interval.